Mechlorethamine
Back to searchMolecule Structure
Scientific Name
Mechlorethamine
Description of the Drug
Mechlorethamine is an antineoplastic agent used to treat Hodgkin’s disease, lymphosarcoma, and chronic myelocytic or lymphocytic leukemia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00888
http://www.drugbank.ca/drugs/DB00888
Brand Name(s)
Not Available
Company Owner(s)
Helsinn Birex Pharmaceuticals Ltd, Recordati Rare Diseases Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
DNA | NUCLEIC-ACID | INHIBITOR | CHEMBL2311221 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL3861 | |||
PharmGKB | PA450336 | |||
Human Metabolome Database | HMDB0015025 | |||
DrugBank | DB00888 | |||
PubChem: Thomson Pharma | 14772371 | |||
PubChem | 4033 | |||
Mcule | MCULE-6341452542 | |||
Nikkaji | J2.305A | |||
BindingDB | 200297 | |||
EPA CompTox Dashboard | DTXSID2020975 | |||
DrugCentral | 1647 | |||
Brenda | 104522 | 106537 | 44590 | |
Guide to Pharmacology | 7218 | |||
rxnorm | VALCHLOR | MECHLORETHAMINE | MECHLORETHAMINE HYDROCHLORIDE | MUSTARGEN |
KEGG Ligand | C07115 | |||
ChEBI | 28925 | |||
ZINC | ZINC000002539484 |